A perspective on liposomal amphotericin B (AmBisome®)

Clinical Microbiology and Infection

Volumn 14, Issue SUPPL. 4, 2008, Pages 1-4

  Richardson, Malcolm ^a   de Pauw, B ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; ECHINOCANDIN;

ASPERGILLOSIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; EDITORIAL; HUMAN; HYPOKALEMIA; MONOTHERAPY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE;

EID: 42649088435     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.01985.x     Document Type: Article

References (9)

1. TJ Walsh EJ Anaissie DW Denning Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360
2. OA Cornely J Maertens M Bresnik Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial) Clin Infect Dis 44 2007 1289 1297
3. R Betts A Glasmacher J Maertens Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients Cancer 106 2006 466 473
4. LS Chou RE Lewis C Ippoliti Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients Pharmacotherapy 27 2007 1644 1650
5. A Madureira A Bergeron C Lacroix Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin Int J Antimicrob Agents 30 2007 551 554
6. C Viscoli R Herbrecht H Akan Caspofungin as first-line therapy of invasive aspergillosis in haematological patients: a study of the EORTC Infectious Diseases Group J Chemother 19 suppl. 3 2007 36
7. O Sivak K Bartlett V Risovic Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis J Pharm Sci 93 2004 1382 1389
8. E Sionov S Mendlovic E Segal Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis J Infect 53 2006 131 139
9. D Caillot A Thiébaut R Herbrecht Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial) Cancer 1100 2007 2740 2746